Application of ATP-TCA in Post-Operative Chemotherapy of Hepatocellular Carcinoma

CHEN Tao,LIU Jian-ping,CHU Zhong-hua,WANG Jie,ZHAO Hai-yan,OU Qing-Jia

DOI: https://doi.org/10.3969/j.issn.1673-5269.2005.19.005

2005-01-01

Abstract:OBJECTIVE:Present chemotherapy regimen is not effective to primary hepatocellular carcinoma (HCC). To improve the outcome of chemotherapy for HCC, in this study, in vitro chemo-drug sensitive testing system-ATP-TCA system was used to direct chemotherapy for HCC patients. METHODS: Tumor tissues were collected from 50 HCC patients. ATP-TCA system was applied. 5-fluorouracil (5-FU), mitomycin (MMC), cisplatin (DDP), oxaliplatin (OXA), epirubicin (EPI), gemcitabine (GEM), irinotecan (CPT-11), etoposide (Vp-16) and paclitaxel (PTX) were tested in the assay. Twenty-three patients received ATP-TCA directed chemotherapy and clinical responses of those patients were further evaluated 20 HCC patients as coatrols.RESULTS: The evaluable rate of ATP-TCA results was 90.8%. In these samples, the sensitive (moderate to high) rates were 46% to PTX, 44% to CPT-11, 36% to GEM, 14% to MMC, 12% to EPI, 8% to DDP, 6% to Vp-16, 6% to OXA and 4% to 5-FU, respectively. In clinical trial, significant differences were found in clinical effectiveness index (CR, PR, SD and PD), P=0.008, overall response rate (ORR), overall survival (OAS), and progress free survival (PFS) between the treatment group and controls, P value=0.043 0, 0.005 7 and 0.004 5, while no significant difference was found in mortality rate between the two groups, P=0.763.CONCLUSIONS: ATP-TCA assay might be useful in evaluating the effectiveness of chemotherapy drugs and in planning individualized regime of chemotherapy for HCC patient clinically. PTX, GEM and CPT-11 might be potential drugs in the treatment of HCC. ATP-TCA guided chemotherapy might be helpful in the treatment of HCC postoperatively.